13F reference period
Q3 2026
Security Snapshot
HCA Healthcare, Inc. - Common Stock, par value $0.01 per share (HCA) Institutional Ownership
CUSIP: 40412C101
13F Institutional Holders and Ownership History from Q1 2014 to Q3 2026
Institutions Reporting
947
Shares (Excl. Options)
71.03M
Full value: 71,026,917 · shares · 30 Sep 2026Price
$426.74
The headline uses the Q3 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended.
Save this security page for your next review
Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, par value $0.01 per share
- Symbol
- HCA on NYSE
- All holders as of 30 Sep 2026
- Q3 2026
- Total 13F shares
- 71,026,917
- Total 13F value
- $30,407,665,236
- Portfolio coverage rank
- 0.02%
- Share change
- -4,033,197
- Value change
- -$1,676,108,686
- Number of holders
- 947
- Shares outstanding
- 208,688,787
- SEC-reported price per share
- $460.75
- Insider filing price
- $460.75
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source
Key facts
- HCA - HCA Healthcare, Inc. - Common Stock, par value $0.01 per share is tracked under CUSIP 40412C101.
- 947 institutions reported positions in Q3 2026.
- 3 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 1,345 to 947 between Q2 2026 and Q3 2026.
- SEC-reported value moved from to
$51.21B
Full value: $51,206,995,564 · USD · 30 Jun 2026.$30.41B
Full value: $30,407,665,236 · USD · 30 Sep 2026
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 947 institutions filings for Q3 2026.
Security key
40412C101
13F reference period
Q3 2026
13F holders
947
13D/G owners
3
CIK / CUSIP context first
Open Q3 2026 holders
HCA full holder history
HCA Healthcare, Inc. SEC filings
HCA Healthcare, Inc. company facts
HCA Healthcare, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 40412C101:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
3
Security
HCA
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Frisco Holding II | 34% | +6.9% | $32,499,835,208 | -$8,652,885 | 70,536,810 | -0.03% | Thomas F. Frist, Jr. | 06 Nov 2026 |
| BlackRock, Inc. | 4.9% | $4,064,772,478 | 12,133,287 | BlackRock, Inc. | 31 Mar 2025 | |||
| VANGUARD CAPITAL MANAGEMENT LLC | 5.2% | $5,558,826,111 | 11,746,315 | Vanguard Capital Management | 31 Mar 2026 |
As of 30 Sep 2026,
947
institutional investors reported holding
shares of
HCA Healthcare, Inc. - Common Stock, par value $0.01 per share (HCA).
This represents
34%
of the company’s total
outstanding shares.
71.03M
Full value: 71,026,917 · shares · 30 Sep 2026208.69M
Full value: 208,688,787 · shares · Stored outstanding share count13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
27%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | 4.5% | 9,421,492 | -7.1% | 0.08% | $4,020,527,496 |
| Sanders Capital, LLC | 4.2% | 8,791,782 | -0.41% | 3.6% | $3,751,805,051 |
| STATE STREET CORP | 3.4% | 6,991,079 | -6.4% | 0.09% | $2,983,373,052 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.7% | 3,506,378 | -4.4% | 0.08% | $1,489,380,591 |
| First Eagle Investment Management, LLC | 1.6% | 3,266,712 | -0.88% | 2.2% | $1,394,036,764 |
| MORGAN STANLEY | 1.3% | 2,635,899 | +1.9% | 0.06% | $1,124,844,603 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 1.2% | 2,555,795 | -5.8% | 0.05% | $1,090,659,958 |
| Capital World Investors | 1.2% | 2,553,170 | +29% | 0.13% | $1,089,549,651 |
| Capital International Investors | 1% | 2,135,069 | +11% | 0.19% | $911,129,365 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 0.96% | 1,996,018 | -9.7% | 0.36% | $851,780,721 |
| NORDEA INVESTMENT MANAGEMENT AB | 0.67% | 1,402,343 | -1.9% | 0.48% | $602,166,084 |
| Invesco Ltd. | 0.64% | 1,331,917 | -13% | 0.04% | $568,382,355 |
| FRANKLIN TEMPLETON INC | 0.58% | 1,215,953 | +19% | 0.13% | $620,987,199 |
| Life Cycle Investment Partners Ltd | 0.51% | 1,070,923 | +17% | 2% | $457,005,681 |
| Metropolis Capital Ltd | 0.42% | 882,944 | -3% | 10% | $376,787,523 |
| VANGUARD FIDUCIARY TRUST CO | 0.4% | 825,890 | -5.2% | 0.08% | $352,440,299 |
| LYRICAL ASSET MANAGEMENT LP | 0.32% | 665,819 | +1.8% | 3.8% | $284,131,600 |
| ROYAL LONDON ASSET MANAGEMENT LTD | 0.31% | 648,167 | +7.2% | 0.51% | $276,598,786 |
| National Pension Service | 0.28% | 592,462 | +0.15% | 0.16% | $252,827,234 |
| Amundi | 0.28% | 576,634 | +61% | 0.05% | $246,072,793 |
| Cryder Capital Partners LLP | 0.27% | 553,683 | +11% | 15% | $236,278,683 |
| DIMENSIONAL FUND ADVISORS LP | 0.21% | 437,799 | -0.8% | 0.03% | $186,846,749 |
| DEUTSCHE BANK AG\ | 0.21% | 427,953 | -5.2% | 0.05% | $182,624,664 |
| Swiss National Bank | 0.2% | 424,720 | -3.8% | 0.1% | $181,245,013 |
| Crake Asset Management LLP | 0.19% | 406,041 | -65% | 3.8% | $173,273,936 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
51
Headline period
Q3 2026
Rows shown
1-25 of 51
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q3 | 71,026,917 | $30,407,665,236 | -$1,676,108,686 | $426.74 | 947 |
| 2026 Q2 | 131,089,331 | $51,206,995,564 | -$190,692,351 | $389.89 | 1,345 |
| 2026 Q1 | 131,465,771 | $62,161,770,090 | -$2,223,855,217 | $473.24 | 1,426 |
| 2025 Q4 | 136,231,999 | $63,581,803,940 | -$942,792,914 | $466.86 | 1,389 |
| 2025 Q3 | 136,800,812 | $58,285,590,997 | -$4,123,517,566 | $426.20 | 1,280 |
| 2025 Q2 | 146,598,810 | $56,127,057,771 | -$1,853,153,800 | $383.10 | 1,239 |
| 2025 Q1 | 152,192,884 | $52,564,357,865 | -$2,006,251,000 | $345.55 | 1,214 |
| 2024 Q4 | 158,412,925 | $47,557,475,465 | -$8,742,290 | $300.15 | 1,169 |
| 2024 Q3 | 157,628,473 | $63,992,248,095 | -$2,602,260,628 | $406.43 | 1,192 |
| 2024 Q2 | 163,570,360 | $52,579,318,347 | -$183,070,166 | $321.28 | 1,151 |
| 2024 Q1 | 163,721,760 | $54,559,435,398 | -$1,094,106,832 | $333.53 | 1,116 |
| 2023 Q4 | 168,060,091 | $45,488,018,617 | -$285,213,231 | $270.68 | 1,047 |
| 2023 Q3 | 169,154,472 | $41,607,918,680 | -$1,185,806,069 | $245.98 | 989 |
| 2023 Q2 | 173,400,079 | $52,556,079,546 | -$666,679,406 | $303.48 | 1,006 |
| 2023 Q1 | 175,196,823 | $46,186,378,435 | -$839,492,963 | $263.68 | 958 |
| 2022 Q4 | 179,614,269 | $43,106,998,862 | -$1,135,008,361 | $239.96 | 949 |
| 2022 Q3 | 184,870,749 | $34,004,075,333 | -$752,760,047 | $183.79 | 849 |
| 2022 Q2 | 188,490,291 | $31,685,644,085 | -$1,589,511,131 | $168.06 | 854 |
| 2022 Q1 | 198,438,957 | $49,759,228,094 | -$1,674,801,898 | $250.62 | 950 |
| 2021 Q4 | 204,993,837 | $52,647,373,530 | -$1,558,591,258 | $256.92 | 931 |
| 2021 Q3 | 210,742,269 | $51,162,204,632 | -$2,696,772,377 | $242.72 | 870 |
| 2021 Q2 | 221,449,830 | $45,771,072,350 | -$1,473,962,964 | $206.74 | 805 |
| 2021 Q1 | 231,377,874 | $43,551,161,088 | -$1,184,824,119 | $188.34 | 777 |
| 2020 Q4 | 237,137,952 | $38,991,278,461 | +$223,535,805 | $164.46 | 765 |
| 2020 Q3 | 237,038,075 | $29,542,477,145 | +$374,442,548 | $124.68 | 709 |